9,10-dimethyl-1,2-benzanthracene has been researched along with diphenylmethyl selenocyanate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharya, S; Das, RK; Das, S; Ghosh, S; Sengupta, A | 1 |
Bhattacharya, S; Das, RK; Hossain, SK | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and diphenylmethyl selenocyanate
Article | Year |
---|---|
Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Croton Oil; Dermatologic Agents; Female; Lipid Peroxidation; Mice; Organoselenium Compounds; Papilloma; Skin Neoplasms | 2004 |
Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Caspase 3; Caspases; Cell Proliferation; Chemoprevention; Croton Oil; Dermatologic Agents; Female; Mice; Organoselenium Compounds; Papilloma; Skin Neoplasms | 2005 |